Item 2. |
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
The following discussion and analysis presents factors that Motorcar Parts of America, Inc. and its subsidiaries (“our,” “we” or “us”) believe are relevant to an assessment and understanding of our consolidated financial
position and results of operations. This financial and business analysis should be read in conjunction with our March 31, 2023 audited consolidated financial statements included in our Annual Report on Form 10-K filed with the Securities and
Exchange Commission (“SEC”) on June 14, 2023.
Disclosure Regarding Private Securities Litigation Reform Act of 1995
This report may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 with respect to our future performance that involve risks and uncertainties. All statements
other than statements of historical fact are forward-looking statements, including, but not limited to, statements about our strategic initiatives, operational plans and objectives, expectations for economic conditions and recovery and future
business and financial performance, as well as statements regarding underlying assumptions related thereto. They include, among others, factors related to the timing and implementation of strategic initiatives, the highly competitive nature of our
industry, demand for our products and services, complexities in our inventory and supply chain, challenges with transforming and growing our business. Except as required by law, we undertake no obligation to revise or update publicly any
forward-looking statements for any reason. Therefore, you should not place undue reliance on those statements. Please refer to “Item 1A. Risk Factors” of our most recent Annual Report
on Form 10-K filed with the SEC on June 14, 2023, as updated by our subsequent filings with the SEC, for a description of these and other risks and uncertainties that could cause actual results to differ materially from those projected or implied
by the forward-looking statements.
Management Overview
With a scalable infrastructure and abundant growth opportunities, we are focused on growing our aftermarket business in the North American marketplace and growing our leadership position in the test solutions and
diagnostic equipment market by providing innovative and intuitive solutions to our customers. Our investments in infrastructure and human resources during the past few years reflects the significant expansion of manufacturing capacity to support
multiple product lines. These investments included (i) a 410,000 square foot distribution center, (ii) two buildings totaling 372,000 square feet for remanufacturing and core sorting of brake calipers, and (iii) the realignment of production at our
original 312,000 square foot facility in Mexico.
Segment Reporting
Effective as of the fourth quarter of fiscal 2023, we revised our segment reporting as we determined that our three operating segments no longer met the criteria to be aggregated. We recast our prior year segment
disclosures to conform to the current year’s presentation.
Our three operating segments are as follows:
|
• |
Hard Parts, including (i) light duty rotating electric products such as alternators and starters, (ii) wheel hub products, (iii) brake-related products, including brake
calipers, brake boosters, brake rotors, brake pads and brake master cylinders, and (iv) turbochargers,
|
|
• |
Test Solutions and Diagnostic Equipment, including (i) applications for combustion engine vehicles, including bench top testers for alternators and starters, (ii) equipment
for the pre- and post-production of electric vehicles, and (iii) software emulation of power systems applications for the electrification of all forms of transportation (including automobiles, trucks, the emerging electrification of systems
within the aerospace industry, and electric vehicle charging stations), and
|
|
• |
Heavy Duty, including non-discretionary automotive aftermarket replacement hard parts for heavy-duty truck, industrial, marine, and agricultural applications.
|
Our Hard Parts operating segment meets the criteria of a reportable segment. The Test Solutions and Diagnostic Equipment and Heavy Duty segments are not material, are not required to be separately reported, and are
included within the “all other” category. See Note 17 of the notes to condensed consolidated financial statements for more information.
Results of Operations for the Three Months Ended June 30, 2023 and 2022
The following discussion and analysis should be read together with the financial statements and notes thereto appearing elsewhere herein.
The following summarizes certain key operating data:
|
|
Three Months Ended
June 30,
|
|
|
|
2023
|
|
|
2022
|
|
Consolidated cash flow used in operations
|
|
$
|
(20,470,000
|
)
|
|
$
|
(982,000
|
)
|
Consolidated finished goods turnover (annualized) (1)
|
|
|
3.5
|
|
|
|
3.1
|
|
|
(1) |
Annualized finished goods turnover for the fiscal quarter is calculated by multiplying cost of goods sold for the quarter by 4 and dividing the result by the average between beginning and ending non-core
finished goods inventory values for the fiscal quarter. We believe this provides a useful measure of our ability to turn our inventory into revenues.
|
Net Sales and Gross Profit
The following summarizes net sales and gross profit:
|
|
Three Months Ended
June 30,
|
|
|
|
2023
|
|
|
2022
|
|
Net sales
|
|
$
|
159,705,000
|
|
|
$
|
163,985,000
|
|
Cost of goods sold
|
|
|
133,138,000
|
|
|
|
133,683,000
|
|
Gross profit
|
|
|
26,567,000
|
|
|
|
30,302,000
|
|
Gross profit percentage
|
|
|
16.6
|
%
|
|
|
18.5
|
%
|
Net Sales. Our net sales for the three months ended June 30, 2023 were $159,705,000, which represents a decrease of $4,280,000, or 2.6%, from the three months ended June 30, 2022
of $163,985,000. Sales for the three months ended June 30, 2023 were impacted by the purchasing patterns of certain of our largest customers, which were partially offset by growing sales of our brake-related products.
Gross Profit. Our gross profit was $26,567,000, or 16.6% of net sales, for the three months ended June 30, 2023 compared with $30,302,000, or 18.5% of net sales, for the three
months ended June 30, 2022. This change in our gross margin for the three months ended June 30, 2023 compared with the three months ended June 30, 2022 was due primarily to changes in product mix and (i) additional expenses of $1,984,000 and
$799,000, respectively, primarily due to certain costs for disruptions in the supply chain, (ii) amortization of core and finished goods premiums paid to customers related to new business of $2,657,000 and
$3,044,000, respectively, and (iii) the non-cash quarterly revaluation of cores that are part of the finished goods on the customers’ shelves (which are included in contract assets) to the lower of cost or net realizable value, which resulted in
a write-down of $778,000 and $572,000, respectively.
Operating Expenses
The following summarizes operating expenses:
|
|
Three Months Ended
June 30,
|
|
|
|
2023
|
|
|
2022
|
|
General and administrative
|
|
$
|
12,602,000
|
|
|
$
|
13,634,000
|
|
Sales and marketing
|
|
|
5,419,000
|
|
|
|
5,542,000
|
|
Research and development
|
|
|
2,375,000
|
|
|
|
3,113,000
|
|
Foreign exchange impact of lease liabilities and forward contracts
|
|
|
(4,270,000
|
)
|
|
|
678,000
|
|
|
|
|
|
|
|
|
|
|
Percent of net sales
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
General and administrative
|
|
|
7.9
|
%
|
|
|
8.3
|
%
|
Sales and marketing
|
|
|
3.4
|
%
|
|
|
3.4
|
%
|
Research and development
|
|
|
1.5
|
%
|
|
|
1.9
|
%
|
Foreign exchange impact of lease liabilities and forward contracts
|
|
|
(2.7
|
)%
|
|
|
0.4
|
%
|
General and Administrative. Our general and administrative expenses for the three months ended June 30, 2023 were $12,602,000, which represents a decrease of $1,032,000, or 7.6%,
from the three months ended June 30, 2022 of $13,634,000. This decrease was primarily due to the favorable foreign currency exchange rates during the three months ended June 30, 2023 as compared with the three months ended June 30, 2022.
Sales and Marketing. Our sales and marketing expenses for the three months ended June 30, 2023 were $5,419,000, which represents a decrease of $123,000, or 2.2%, from the three
months ended June 30, 2022 of $5,542,000. This decrease was primarily due to $258,000 of decreased employee-related expenses due to our cost-cutting measures partially offset by $172,000 of increased commissions.
Research and Development. Our research and development expenses for the three months ended June 30, 2023 were $2,375,000, which represents a decrease of $738,000, or 23.7%, from
the three months ended June 30, 2022 of $3,113,000. This decrease was primarily due to (i) $427,000 of decreased employee-related expenses due to our cost-cutting measures, (ii) $178,000 of decreased outside services, and (iii) $121,000 of
decreased purchases of samples for our core library and other research and development supplies.
Foreign Exchange Impact of Lease Liabilities and Forward Contracts. Our foreign exchange impact of lease liabilities and forward contracts for the three months ended June 30, 2023
was a non-cash gain of $4,270,000 compared with a non-cash loss of $678,000 for the three months ended June 30, 2022. This change was primarily due to (i) the remeasurement of our foreign currency-denominated lease liabilities, which resulted in
non-cash gains of $3,770,000 and $20,000 for the three months ended June 30, 2023 and 2022, respectively, due to foreign currency exchange rate fluctuations and (ii) the forward foreign currency exchange contracts, which resulted in a non-cash gain
of $500,000 compared with a non-cash loss of $698,000 for the three months ended June 30, 2023 and 2022, respectively, due to the changes in their fair values.
Operating Income
Consolidated Operating Income. Our consolidated operating income for the three months ended June 30, 2023 was $10,441,000, which represents an increase of $3,106,000, or 42.3%,
from the three months ended June 30, 2022 of $7,335,000. Operating income increased primarily due to lower operating expenses partially offset by decreased gross profit as discussed above.
Interest Expense
Interest Expense, net. Our interest expense for the three months ended June 30, 2023 was $11,720,000, which represents an increase of $4,799,000, or 69.3%, from interest expense
for the three months ended June 30, 2022 of $6,921,000. This increase was primarily due to higher interest rates on our borrowing and accounts receivable discount programs, which have variable interest rates. Interest expense for the three months
ended June 30, 2023 was further impacted by interest expense incurred on the Convertible Notes.
Change in Fair Value of Compound Net Derivative Liability
Change in Fair Value of Compound Net Derivative Liability. Our change in fair value of compound net derivative liability for the three months ended June 30, 2023 was a non-cash
loss of $140,000 associated with the Convertible Notes issued on March 31, 2023.
Provision for Income Taxes
Income Tax. We recorded an income tax benefit of $9,000, or an effective tax rate of 0.6%, and income tax expense of $589,000, or an effective tax rate of 142.3%, for the three
months ended June 30, 2023 and 2022, respectively. Effective tax rates are based on current annual projections and any changes in future periods could result in an effective tax rate that is materially different from the current estimate. The
effective tax rate for the three months ended June 30, 2023, was primarily impacted by (i) foreign income taxed at rates that are different from the federal statutory rate, (ii) non-deductible executive compensation under Internal Revenue Code
Section 162(m), and (iii) specific jurisdictions that we do not expect to recognize the benefit of losses.
Liquidity and Capital Resources
Overview
We had working capital (current assets minus current liabilities) of $153,726,000 and $154,886,000, a ratio of current assets to current liabilities of 1.4:1.0, at June 30, 2023 and March 31, 2023, respectively. The
change in our working capital is due to the short-term classification of our term loans as we plan to repay the outstanding balance in August 2023 partially offset by the replenishment of our inventory due to higher sales in the prior year.
We have $32,000,000 of aggregate principal amount of convertible notes outstanding that bear interest at a rate of 10% per year. The convertible notes may either be redeemed for cash, converted into shares of our common
stock, or a combination thereof, at our election. The convertible notes will mature on March 30, 2029, unless earlier converted, repurchased or redeemed.
Our primary source of liquidity was from the use of our receivable discount programs and credit facility during the three months ended June 30, 2023. In addition, we have access to our existing cash, as well as our
available credit facilities to meet short-term liquidity needs. We believe our cash and cash equivalents, use of receivable discount programs, amounts available under our credit facility, and other sources are sufficient to satisfy our expected
future working capital needs, repayment of our term loans, and lease and capital expenditure obligations over the next 12 months.
Share Repurchase Program
In August 2018, our board of directors approved an increase in our share repurchase program from $20,000,000 to $37,000,000 of our common stock. As of June 30, 2023, $18,745,000 had been utilized and $18,255,000 remains
available to repurchase shares under the authorized share repurchase program, subject to the limit in our credit facility. We retired the 837,007 shares repurchased under this program through June 30, 2023. Our share repurchase program does not
obligate us to acquire any specific number of shares and shares may be repurchased in privately negotiated and/or open market transactions.
Cash Flows
The following summarizes cash flows as reflected in the condensed consolidated statements of cash flows:
|
|
Three Months Ended
June 30,
|
|
|
|
2023
|
|
|
2022
|
|
Cash flows (used in) provided by:
|
|
|
|
|
|
|
Operating activities
|
|
$
|
(20,470,000
|
)
|
|
$
|
(982,000
|
)
|
Investing activities
|
|
|
(67,000
|
)
|
|
|
(1,461,000
|
)
|
Financing activities
|
|
|
19,673,000
|
|
|
|
(11,266,000
|
)
|
Effect of exchange rates on cash and cash equivalents
|
|
|
155,000
|
|
|
|
(90,000
|
)
|
Net decrease in cash and cash equivalents
|
|
$
|
(709,000
|
)
|
|
$
|
(13,799,000
|
)
|
Additional selected cash flow data:
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
$
|
3,033,000
|
|
|
$
|
3,124,000
|
|
Capital expenditures
|
|
|
40,000
|
|
|
|
1,375,000
|
|
Net cash used in operating activities was $20,470,000 and $982,000 during the three months ended June 30, 2023 and 2022, respectively. The change in our operating activities reflects our higher accounts receivable
balances as we managed the use of our customers’ receivable discount programs and replenishment of inventory due to higher sales in the prior year.
Net cash used in investing activities was $67,000 and $1,461,000 during the three months ended June 30, 2023 and 2022, respectively. The change in our investing activities primarily resulted from decreased capital
expenditures.
Net cash provided by financing activities was $19,673,000 compared with cash used in financing activities of $11,266,000 during the three months ended June 30, 2023 and 2022, respectively. The change in our financing
activities resulted from increased borrowing and lower repayments under our credit facility as we managed the use of our customers’ receivable discount programs to reduce overall interest expense during the three months ended June 30, 2023.
Capital Resources
Credit Facility
We are party to a $268,620,000 senior secured financing (as amended from time to time, the “Credit Facility”) consisting of a $238,620,000 revolving loan facility (the “Revolving Facility”), subject to certain
restrictions, and a $30,000,000 term loan facility (the “Term Loans”). The loans under the Credit Facility mature on May 28, 2026 and the lenders have a security interest in substantially all of our assets. The interest rate on our Term Loans and
Revolving Facility was 8.52% and 8.46% respectively, at June 30, 2023, and 8.02% and 8.13% respectively, at March 31, 2023.
On August 3, 2023, we entered into a seventh amendment to the Credit Facility, which among other things, (i) permits us to repay our outstanding balance of Term Loans, (ii) permits the exclusion of quarterly principal
payments of Term Loans from the fixed charge coverage ratio (including retrospectively for the prior periods) for all quarters beginning June 30, 2023, (iii) resets the fixed charge coverage ratio financial covenant level for the quarters ending
September 30, 2023 and December 31, 2023, (iv) eliminates the senior leverage ratio financial covenant effective with the quarter ended June 30, 2023, (v) extends the minimum undrawn availability financial covenant through the delivery of the June
30, 2024 compliance certificate, and (vi) excludes the amount of all amendment fees and expenses incurred in connection with this amendment as well as prior unamortized fees associated with the Term Loans from bank EBITDA and the fixed charge
coverage ratio financial covenant. The modifications to the financial covenants were effective as of June 30, 2023. On August 3, 2023, we repaid the outstanding balance of our Term Loans and wrote-off the remaining unamortized financing fees
recorded in connection with the Term Loans.
The Credit Facility, among other things, requires us to maintain certain financial covenants, including a maximum senior leverage ratio and a minimum fixed charge coverage ratio. We were in compliance with all amended
financial covenants as of June 30, 2023.
We had $167,000,000 and $145,200,000 outstanding under the Revolving Facility at June 30, 2023 and March 31, 2023, respectively. In addition, $6,370,000 was outstanding for letters of credit at June 30, 2023. At June 30,
2023, after certain contractual adjustments, $65,250,000 was available under the Revolving Facility.
Convertible Notes
On March 31, 2023, we entered into a note purchase agreement, (the “Note Purchase Agreement”) with Bison Capital Partners VI, L.P. and Bison Capital Partners VI-A, L.P. (collectively, the “Purchasers”) and Bison Capital
Partners VI, L.P., as the purchaser representative (the “Purchaser Representative”) for the issuance and sale of $32,000,000 in aggregate principal amount of convertible notes due in 2029 (the “Convertible Notes”), which was used for general
corporate purposes. The Convertible Notes bear interest at a rate of 10.0% per annum, compounded annually, and payable (i) in kind or (ii) in cash, annually in arrears on April 1 of each year, commencing on April 1, 2024. The Convertible Notes have
an initial conversion price of approximately $15.00 per share of common stock. (“Conversion Option”). Unless and until we deliver a redemption notice, the Purchasers of the Convertible Notes may convert their Convertible Notes at any time at their
option. Upon conversion, the Convertible Notes will be settled in shares of our common stock. Except in the case of the occurrence of a fundamental transaction, as defined in the form of convertible promissory note, we may not redeem the
Convertible Notes prior to March 31, 2026. After March 31, 2026, we may redeem all or part of the Convertible Notes for a cash purchase (the “Company Redemption”) price.
On June 8, 2023, we entered into the first amendment to the Note Purchase Agreement, which among other things, removed a provision that specified the Purchasers would be entitled to receive a dividend or distribution
payable in certain circumstances. This amendment was effective as of March 31, 2023.
On August 1, 2023, we entered into the second amendment to the Note Purchase Agreement, which amended the definition of “Permitted Restricted Payments” to permit the prepayment of our Term Loans.
In connection with the Note Purchase Agreement, we entered into common stock warrants (the “Warrants”) with the Purchasers, which mature on March 30, 2029. The fair value of the Warrants, using Level 3 inputs and the
Monte Carlo simulation model, was zero at June 30, 2023 and March 31, 2023.
The Company Redemption option has been combined with the Conversion Option as a compound net derivative liability (the “Compound Net Derivative Liability”). The Compound Net Derivative Liability has been recorded within
convertible note, related party in the condensed consolidated balance sheets at June 30, 2023 and March 31, 2023. The fair value of the Conversion Option and the Company Redemption option using Level 3 inputs and the Monte Carlo simulation model
was a liability of $10,800,000 and $10,400,000, and an asset of $2,230,000 and $1,970,000 at June 30, 2023 and March 31, 2023, respectively. During the three months ended June 30, 2023, we recorded $140,000 as the change in fair value of Compound
Net Derivative Liability in the condensed consolidated statement of operations and condensed consolidated statement of cash flows.
The Convertible Notes also contain additional features, such as, default interest and options related to a fundamental transaction, which were not separately accounted for as the value of such features were not material
at June 30, 2023 and March 31, 2023.
Receivable Discount Programs
We use receivable discount programs with certain customers and their respective banks. Under these programs, we have options to sell those customers’ receivables to those banks at a discount to be agreed upon at the time
the receivables are sold. These discount arrangements allow us to accelerate receipt of payment on customers’ receivables. While these arrangements have reduced our working capital needs, there can be no assurance that these programs will continue
in the future. Interest expense resulting from these programs would increase if interest rates rise, if utilization of these discounting arrangements expands, if customers extend their payment to us, or if the discount period is extended to reflect
more favorable payment terms to customers.
The following is a summary of the receivable discount programs:
|
|
Three Months Ended
June 30,
|
|
|
|
2023
|
|
|
2022
|
|
Receivables discounted
|
|
$
|
104,332,000
|
|
|
$
|
142,624,000
|
|
Weighted average number of days collection was accelerated
|
|
|
337
|
|
|
|
327
|
|
Annualized weighted average discount rate
|
|
|
6.4
|
%
|
|
|
3.7
|
%
|
Amount of discount recognized as interest expense
|
|
$
|
6,252,000
|
|
|
$
|
4,874,000
|
|
Capital Expenditures and Commitments
Capital Expenditures
Our total capital expenditures, including finance leases and non-cash capital expenditures were $64,000 and $1,190,000 for the three months ended June 30, 2023 and 2022, respectively. These capital expenditures primarily
include the purchase of equipment for our current operations. We expect to incur approximately $5,000,000 of capital expenditures primarily to support our current operations during fiscal 2024. We have used and expect to continue using our working
capital and additional capital lease obligations to finance these capital expenditures.
Related Party Transactions
Lease
In December 2022, we entered into an operating lease for our 35,000 square foot manufacturing, warehouse, and office facility in Ontario, Canada, with a company co-owned by a member of management. The lease, which
commenced January 1, 2023, has an initial term of one year with a base rent of approximately $27,000 per month and includes options to renew for up to four years. The rent expense recorded for the related party lease was $81,000 for the three
months ended June 30, 2023.
Litigation
We are subject to various lawsuits and claims. In addition, government agencies and self-regulatory organizations have the ability to conduct periodic examinations of and administrative proceedings regarding our business,
and our compliance with law, code, and regulations related to all matters including but not limited to environmental, information security, taxes, levies, tariffs and such.
Critical Accounting Policies
There have been no material changes to our critical accounting policies and estimates that are presented in our Annual Report on Form 10-K for the year ended March 31, 2023, which was filed on June 14, 2023.
Item 3. |
Quantitative and Qualitative Disclosures About Market Risk
|
There have been no material changes in market risk from the information provided in Item 7A. “Quantitative and Qualitative Disclosures About Market Risk” in our Annual Report on Form 10-K as of March 31, 2023, which was
filed with the SEC on June 14, 2023.
Item 4. |
Controls and Procedures
|
Evaluation of Disclosure Controls and Procedures
We have established disclosure controls and procedures designed to ensure that the information required to be disclosed by the Company in the reports that it files or submits under the Securities Exchange Act of 1934 is
recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms and that such information is accumulated and communicated to management, including our chief executive officer, chief financial officer, and
chief accounting officer, as appropriate to allow timely decisions regarding required disclosures.
Under the supervision and with the participation of management, including our chief executive officer, chief financial officer, and chief accounting officer, we have conducted an evaluation of the effectiveness of our
disclosure controls and procedures as defined in Exchange Act Rules 13a-15(e) and 15d-15(e). Based on this evaluation, our chief executive officer, chief financial officer, and chief accounting officer concluded that MPA’s disclosure controls and
procedures were effective as of June 30, 2023.
Inherent Limitations on Effectiveness of Controls
The Company’s management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Exchange Act Rules 13a-15(f) and 15d-15(f).
Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in
accordance with accounting principles generally accepted in the United States of America, applying certain estimates and judgments as required.
Internal control over financial reporting includes those policies and procedures that:
1. Pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company;
2. Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of
the Company are being made only in accordance with authorizations of management and directors of the Company; and
3. Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that
controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Changes in Internal Control Over Financial Reporting
There have been no changes in our internal control over financial reporting (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) that occurred during the three months ended
June 30, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
PART II — OTHER INFORMATION
Item 1. |
Legal Proceedings
|
We are subject to various lawsuits and claims. In addition, government agencies and self-regulatory organizations have the ability to conduct periodic examinations of and administrative proceedings regarding our business,
and our compliance with law, code, and regulations related to all matters including but not limited to environmental, information security, taxes, levies, tariffs and such.
There have been no material changes in the risk factors set forth in Item 1A to Part I of our Annual Report on Form 10-K for the fiscal year ended March 31, 2023, filed on June 14, 2023.
Item 2. |
Unregistered Sales of Equity Securities and Use of Proceeds
|
Limitation on Payment of Dividends and Share Repurchases
The Credit Facility currently permits the payment of up to $30,000,000 of dividends and share repurchases for fiscal year 2024, subject to pro forma compliance with amended financial covenants.
Purchases of Equity Securities by the Issuer
Shares repurchased during the three months ended June 30, 2023 were as follows:
Periods
|
|
Total Number of
Shares Purchased
|
|
|
Average Price
Paid Per Share
|
|
|
Total Number of
Shares Purchased
as Part of Publicly
Announced Plans
or Programs
|
|
|
Approximate
Dollar Value of
Shares That May
Yet Be Purchased
Under the Plans
or Programs (1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
April 1 - April 30, 2023:
|
|
|
|
|
|
|
|
|
|
|
|
|
Open market and privately negotiated purchases
|
|
|
-
|
|
|
$
|
-
|
|
|
|
-
|
|
|
$
|
18,255,000
|
|
May 1 - May 31, 2023:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Open market and privately negotiated purchases
|
|
|
-
|
|
|
$
|
-
|
|
|
|
-
|
|
|
|
18,255,000
|
|
June 1 - June 30, 2023:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Open market and privately negotiated purchases
|
|
|
-
|
|
|
$
|
-
|
|
|
|
-
|
|
|
|
18,255,000
|
|
Total
|
|
|
0
|
|
|
|
|
|
|
|
0
|
|
|
$
|
18,255,000
|
|
|
(1) |
As of June 30, 2023, $18,745,000 had been utilized and $18,255,000 remains available to repurchase shares under the authorized share repurchase program, subject to the limit in our Credit Facility. We retired
the 837,007 shares repurchased under this program through June 30, 2023. Our share repurchase program does not obligate us to acquire any specific number of shares and shares may be repurchased in privately negotiated and/or open market
transactions.
|
Item 3. |
Defaults Upon Senior Securities
|
None.
Item 5. |
Other Information
|
(c) |
During the quarter ended June 30, 2023, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement” as each such term is defined in Item 408 of
Regulation S-K.
|
Number
|
|
Description of Exhibit
|
|
Method of Filing
|
|
|
|
|
|
3.1
|
|
Certificate of Incorporation of the Company
|
|
Incorporated by reference to Exhibit 3.1 to the Company’s Registration Statement on Form SB-2 declared effective on March 22, 1994 (the “1994 Registration Statement”).
|
|
|
|
|
|
3.2
|
|
Amendment to Certificate of Incorporation of the Company
|
|
Incorporated by reference to Exhibit 3.2 to the Company’s Registration Statement on Form S-1 (No. 33-97498) declared effective on November 14, 1995.
|
|
|
|
|
|
|
|
Amendment to Certificate of Incorporation of the Company
|
|
Incorporated by reference to Exhibit 3.3 to the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 1997.
|
|
|
|
|
|
|
|
Amendment to Certificate of Incorporation of the Company
|
|
Incorporated by reference to Exhibit 3.4 to the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 1998 (the “1998 Form 10-K”).
|
|
|
|
|
|
|
|
Amendment to Certificate of Incorporation of the Company
|
|
Incorporated by reference to Exhibit C to the Company’s proxy statement on Schedule 14A filed with the SEC on November 25, 2003.
|
|
|
|
|
|
|
|
Amended and Restated By-Laws of Motorcar Parts of America, Inc.
|
|
Incorporated by reference to Exhibit 3.1 to Current Report on Form 8-K filed on August 24, 2010.
|
|
|
|
|
|
|
|
Certificate of Amendment of the Certificate of Incorporation of the Company
|
|
Incorporated by reference to Exhibit 3.1 to Current Report on Form 8-K filed on April 17, 2014.
|
|
|
|
|
|
|
|
Amendment to the Amended and Restated By-Laws of Motorcar Parts of America, Inc., as adopted on June 9, 2016
|
|
Incorporated by reference to Exhibit 3.1 to Current Report on Form 8-K filed on June 14, 2016.
|
|
|
|
|
|
|
|
Amendment to the Amended and Restated By-Laws of the Company
|
|
Incorporated by reference to Exhibit 3.1 to Current Report on Form 8-K filed on February 22, 2017.
|
|
|
|
|
|
|
|
Third Amendment to the Amended and Restated By-Laws of Motorcar Parts of America, Inc., as adopted on January 26, 2022
|
|
Incorporated by reference to Exhibit 3.1 to Current Report on Form 8-K filed on February 1, 2022.
|
|
|
|
|
|
|
|
Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
|
|
Incorporated by reference to Exhibit 4.1 to Quarterly Report on Form 10-Q filed on August 9, 2022.
|
|
|
|
|
|
|
|
2004 Non-Employee Director Stock Option Plan
|
|
Incorporated by reference to Appendix A to the Proxy Statement on Schedule 14A for the 2004 Annual Shareholders Meeting.
|
|
|
|
|
|
|
|
2010 Incentive Award Plan
|
|
Incorporated by reference to Appendix A to the Proxy Statement on Schedule 14A filed on December 15, 2010.
|
|
|
|
|
|
|
|
Amended and Restated 2010 Incentive Award Plan
|
|
Incorporated by reference to Appendix A to the Proxy Statement on Schedule 14A filed on March 5, 2013.
|
Number
|
|
Description of Exhibit
|
|
Method of Filing
|
|
|
|
|
|
|
|
Second Amended and Restated 2010 Incentive Award Plan
|
|
Incorporated by reference to Appendix A to the Proxy Statement on Schedule 14A filed on March 3, 2014.
|
|
|
|
|
|
|
|
2014 Non-Employee Director Incentive Award Plan
|
|
Incorporated by reference to Appendix B to the Proxy Statement on Schedule 14A filed on March 3, 2014.
|
|
|
|
|
|
|
|
Third Amended and Restated 2010 Incentive Award Plan
|
|
Incorporated by reference to Appendix A to the Proxy Statement on Schedule 14A filed on November 20, 2017.
|
|
|
|
|
|
|
|
Fourth Amended and Restated 2010 Incentive Award Plan
|
|
Incorporated by reference to Appendix A to the Proxy Statement on Schedule 14A filed on July 24, 2020.
|
|
|
|
|
|
|
|
2022 Incentive Award Plan
|
|
Incorporated by reference to Appendix A to the Proxy Statement on Schedule 14A filed on July 29, 2022.
|
|
|
|
|
|
|
|
Form of Convertible Promissory Note
|
|
Incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K filed on March 31, 2023.
|
|
|
|
|
|
|
|
Form of Common Stock Warrant
|
|
Incorporated by reference to Exhibit 4.2 to the Current Report on Form 8-K filed on March 31, 2023.
|
|
|
|
|
|
|
|
First Amended and Restated Convertible Promissory Note
|
|
Incorporated by reference to Exhibit 4.12 to the Annual Report on Form 10-K filed on June 14, 2023.
|
|
|
|
|
|
|
|
First Amended and Restated Common Stock Warrant
|
|
Incorporated by reference to Exhibit 4.13 to the Annual Report on Form 10-K filed on June 14, 2023.
|
|
|
|
|
|
|
|
Seventh Amendment to Amended and Restated Loan Agreement, dated as of August 3, 2023, among Motorcar Parts of America, Inc., D & V Electronics Ltd., Dixie Electric Ltd., and Dixie Electric Inc., each
lender from time to time party thereto, and PNC Bank, National Association, as administrative agent
|
|
Filed herewith.
|
|
|
|
|
|
|
|
Second Amendment to the Note Purchase Agreement
|
|
Filed herewith.
|
|
|
|
|
|
|
|
Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes Oxley Act of 2002
|
|
Filed herewith.
|
|
|
|
|
|
|
|
Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes Oxley Act of 2002
|
|
Filed herewith.
|
|
|
|
|
|
|
|
Certification of Chief Accounting Officer pursuant to Section 302 of the Sarbanes Oxley Act of 2002
|
|
Filed herewith.
|
|
|
|
|
|
|
|
Certifications of Chief Executive Officer, Chief Financial Officer and Chief Accounting Officer pursuant to Section 906 of the Sarbanes Oxley Act of 2002
|
|
Filed herewith.
|
Number
|
|
Description of Exhibit
|
|
Method of Filing
|
|
|
|
|
|
101.INS
|
|
Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the inline XBRL document).
|
|
|
|
|
|
|
|
101.SCM
|
|
Inline XBRL Taxonomy Extension Schema Document
|
|
|
|
|
|
|
|
101.CAL
|
|
Inline XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
|
|
|
|
101.DEF
|
|
Inline XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
|
|
|
|
101.LAB
|
|
Inline XBRL Taxonomy Extension Label Linkbase Document
|
|
|
|
|
|
|
|
101.PRE
|
|
Inline XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
|
|
|
|
|
104
|
|
Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)
|
|
|
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
MOTORCAR PARTS OF AMERICA, INC.
|
|
|
|
Dated: August 9, 2023
|
By:
|
/s/ David Lee
|
|
|
David Lee
|
|
|
Chief Financial Officer
|
|
|
|
Dated: August 9, 2023
|
By:
|
/s/ Kamlesh Shah
|
|
|
Kamlesh Shah
|
|
|
Chief Accounting Officer
|
36